Literature DB >> 14736524

Risk factors for malignancy in multinodular goitres.

A Ríos1, J M Rodríguez, M Canteras, P J Galindo, M D Balsalobre, P Parrilla.   

Abstract

BACKGROUND: Multinodular goitre (MNG) is quite often associated with thyroid carcinoma, but the risk factors for malignancy are not well known. The aim is to analyse patients with thyroid carcinoma associated with MNG to determine the clinical risk factors for malignancy.
METHOD: From a series of 672 MNGs we analysed a subgroup of 59 patients presenting with an associated thyroid carcinoma. The variables analysed were age, sex, family history, cervical radiation therapy, residence in areas of endemic goitre, prior thyroid surgery, time of evolution, asymptomatic status, hyperthyroidism, compressive syndromes, intrathoracic prolongation, goitre consistency and cervical adenopathies. These were compared to MNGs not developing malignancy using the Chi-squared test, Student's t test and a logistic regression test.
RESULTS: Of the 59 cases, 37 corresponded to a microcarcinoma (< or =1 cm). The most common histological type was papillary (n=48), followed by follicular (n=6). In 20 cases the carcinoma was multifocal, and capsular involvement was noted in 16 patients, lymph node involvement in five and vascular involvement in another five. The multivariate analysis confirmed the following as independent variables associated with the presence of carcinoma: family history of thyroid pathology (RR=1.6), history of cervical radiation therapy (RR=1.8), recurrent goitre (RR=2.1) and presence of adenopathies on physical exploration (RR=1.6).
CONCLUSION: The risk factors for carcinoma associated with MNG are family history of thyroid pathology, personal history of cervical radiation therapy, prior surgery and presence of cervical adenopathies.

Entities:  

Mesh:

Year:  2004        PMID: 14736524     DOI: 10.1016/j.ejso.2003.10.021

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  12 in total

1.  'Aggressive papillary' thyroid microcarcinoma.

Authors:  Cyril Page; Aurélie Biet; Pierrick Boute; Philippe Cuvelier; Vladimir Strunski
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-03-18       Impact factor: 2.503

2.  Management of retrosternal goitres.

Authors:  R G Hardy; R D Bliss; T W J Lennard; S P Balasubramanian; B J Harrison
Journal:  Ann R Coll Surg Engl       Date:  2009-01       Impact factor: 1.891

3.  A Conservative Approach Is Reasonable in Patients with Non-Toxic Goitre: Results from an Observational Study during 30 Years.

Authors:  Johannes Järhult; Ramtin Vedad
Journal:  Eur Thyroid J       Date:  2014-10-15

4.  Substernal thyroid biopsy using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration.

Authors:  Abhishek Kumar; Arjun Mohan; Samjot S Dhillon; Kassem Harris
Journal:  J Vis Exp       Date:  2014-11-10       Impact factor: 1.355

5.  Papillary thyroid carcinoma presenting as a solitary soft tissue arm metastasis in an elderly hyperthyroid patient. Case report and review of the literature.

Authors:  Angela Pucci; Monica Suppo; Giovanni Lucchesi; Angela Celeste; Laura Viberti; Riccardo Pellerito; Mauro Papotti
Journal:  Virchows Arch       Date:  2006-03-28       Impact factor: 4.064

6.  Significantly high expression of platelet-derived growth factor (PDGF) in benign nodules of the thyroid: relevance in the development of goitre recurrence?

Authors:  Patrizia Malkomes; Elsie Oppermann; Wolf-Otto Bechstein; Katharina Holzer
Journal:  Langenbecks Arch Surg       Date:  2011-05-08       Impact factor: 3.445

Review 7.  Modeling thyroid cancer in the mouse.

Authors:  X-G Zhu; S-Y Cheng
Journal:  Horm Metab Res       Date:  2009-04-08       Impact factor: 2.936

8.  Characteristics of well-differentiated thyroid cancer associated with multinodular goiter.

Authors:  Shih-Ping Cheng; Chien-Liang Liu; Chi-Yuan Tzen; Tsen-Long Yang; Kuo-Shyang Jeng; Tsang-Pai Liu; Jie-Jen Lee
Journal:  Langenbecks Arch Surg       Date:  2008-04-11       Impact factor: 3.445

9.  New prognostic scales LAST-1 and LAST-2: supporting prediction and staging of thyroid cancer.

Authors:  Andrzej J Lachinski; Tomasz Stefaniak; Jarek Kobiela; Saxon Connor; Zbigniew Gruca; Zbigniew Sledzinski
Journal:  World J Surg       Date:  2006-03       Impact factor: 3.352

10.  Evidence-based surgical management of substernal goiter.

Authors:  Matthew L White; Gerard M Doherty; Paul G Gauger
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.